Consonance Capital Management as of June 30, 2013
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 19 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Salix Pharmaceuticals | 11.0 | $31M | 468k | 66.15 | |
| NPS Pharmaceuticals | 9.9 | $28M | 1.8M | 15.11 | |
| United Therapeutics Corporation (UTHR) | 9.6 | $27M | 408k | 65.82 | |
| Medicines Company | 9.1 | $26M | 835k | 30.76 | |
| Ariad Pharmaceuticals | 8.3 | $23M | 1.3M | 17.49 | |
| Furiex Pharmaceuticals | 7.9 | $22M | 651k | 34.07 | |
| Jazz Pharmaceuticals (JAZZ) | 7.7 | $22M | 313k | 68.73 | |
| AMAG Pharmaceuticals | 5.8 | $16M | 737k | 22.25 | |
| Affymetrix | 5.4 | $15M | 3.4M | 4.44 | |
| Emergent BioSolutions (EBS) | 5.0 | $14M | 984k | 14.42 | |
| Cardiovascular Systems | 4.7 | $13M | 623k | 21.20 | |
| Vanda Pharmaceuticals (VNDA) | 4.1 | $12M | 1.4M | 8.08 | |
| Questcor Pharmaceuticals | 3.2 | $9.1M | 200k | 45.44 | |
| Taro Pharmaceutical Industries (TARO) | 2.7 | $7.5M | 134k | 55.90 | |
| Clovis Oncology | 2.0 | $5.5M | 83k | 66.98 | |
| Chindex International | 1.9 | $5.4M | 335k | 16.22 | |
| Liposcience | 1.1 | $3.0M | 422k | 6.99 | |
| Sucampo Pharmaceuticals | 0.4 | $1.2M | 180k | 6.58 | |
| Amarin Corporation (AMRN) | 0.2 | $673k | 116k | 5.80 |
